Quick Nav

Foundation Makes AIDS Drug Deal

Published Online: Wednesday, February 1, 2006   [ Request Print ]

African and Caribbean nations ravaged by the HIV epidemic will be able to obtain low-cost generic versions of 2 key antiretroviral drugs under a deal brokered by former President Bill Clinton's AIDS Foundation.

Under the arrangement, poor countries—including Swaziland, Lesotho, Seychelles, Mauritius, and Madagascar—will get access to generic efavirenz and abacavir at prices that have been estimated at $240 per patient per year.

Aspen Pharmacare and Indian generic drug manufacturers Ranbaxy, Cipla, and Strides Acrolabs will supply efavirenz. Cipla will also supply abacavir.

Related Articles
No Result Found

Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-257-0701

Copyright HCPLive 2006-2013
Intellisphere, LLC. All Rights Reserved.

Become a Member
Forgot Password?